ClassID:

95491

C07D498/02 - CPC Classification

Classification description:

Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings

Sub-classes:
Recent Application in this class:
#1
20260138983
2026-05-21

FGFR Inhibitors and Methods of Use Thereof

#2
20260091048
2026-04-02

GIP RECEPTOR AGONIST COMPOUNDS

#3
20250114374
2025-04-10

BCL-2 INHIBITORS

#4
20230192709
2023-06-22

FGFR inhibitors and methods of use thereof

#5
20230104574
2023-04-06

FGFR INHIBITORS AND METHODS OF USE THEREOF

#6
20220298155
2022-09-22

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

#7
20220098215
2022-03-31

DUOCARMYCIN ANALOGUES

#8
20220073536
2022-03-10

METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS

#9
20210284655
2021-09-16

LIBRARIES OF HETEROARYL-CONTAINING MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#10
20200308163
2020-10-01

Compounds and compositions as modulators of TLR signaling

#11
20200157116
2020-05-21

Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same

#12
20200017523
2020-01-16

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#13
20190375763
2019-12-12

Reagents for reversibly protecting biological molecules

#14
20180370973
2018-12-27

Fused heteroaryl derivatives as orexin receptor antagonists

#15
20180265521
2018-09-20

Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same

#16
20180072756
2018-03-15

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#17
20170158708
2017-06-08

Antibacterial compounds

#18
20150038703
2015-02-05

Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications

#19
20140221422
2014-08-07

Thienopyridine compounds, and methods of use thereof

#20
20140121203
2014-05-01

Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications

#21
20130143896
2013-06-06

Isoxazolo-quinazolines as modulators of protein kinase activity

#22
20120253039
2012-10-04

Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds

#23
20120046757
2012-02-23

COVALENT MODIFICATION OF METAL SURFACES

#24
20110077408
2011-03-31

Organic dye used in dye-sensitized solar cell

#25
20100152160
2010-06-17

NOVEL BENZODIOXANE AND BENZOXAZINE DERIVATIVES USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS

#26
20100105721
2010-04-29

Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications

#27
20090318687
2009-12-24

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#28
20090043103
2009-02-12

Organic dye used in dye-sensitized solar cell

#29
20090023916
2009-01-22

Tetrazine-based bio-orthogonal coupling reagents and methods

#30
20080312438
2008-12-18

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#31
20080227807
2008-09-18

5-lipoxygenase-activating protein (FLAP) inhibitors

#32
20080221128
2008-09-11

Metalloprotease inhibitors containing a squaramide moiety

#33
20080221095
2008-09-11

Metalloprotease inhibitors containing a heterocyclic moiety

#34
20080221094
2008-09-11

Metalloprotease inhibitors containing a squaramide moiety

#35
20080221093
2008-09-11

Metalloprotease inhibitors containing a heterocyclic moiety

#36
20080221091
2008-09-11

Metalloprotease inhibitors containing a heterocyclic moiety

#37
20080085896
2008-04-10

Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications

#38
20080035243
2008-02-14

Covalent modification of metal surfaces

#39
20070225495
2007-09-27

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#40
20070179149
2007-08-02

Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors

#41
20070167439
2007-07-19

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#42
20070149553
2007-06-28

Mitotic kinesin inhibitors

#43
20070123522
2007-05-31

5-lipoxygenase-activating protein (FLAP) inhibitors

#44
20070073052
2007-03-29

Organic dye used in dye-sensitized solar cell

#45
20060293322
2006-12-28

Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders

#46
20060229314
2006-10-12

Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors

#47
20060199836
2006-09-07

Thienopyridine compounds, and methods of use thereof

#48
20050256152
2005-11-17

Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations

#49
20050234049
2005-10-20

Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

#50
20050209224
2005-09-22

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#51
20050203122
2005-09-15

Benzenesulfonic acid salts of clopidogrel, methods for preparing same, and pharmaceutical formulations thereof